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programAbstract COPD has signiﬁcant extrapulmonary effects as weight loss, nutritional abnormalities,
and skeletal muscle dysfunction. Pulmonary rehabilitation (PR) programs are beneﬁcial to
COPD in order to improve exercise capacity, muscle force, symptoms, and health-related quality
of life.
The aim of this study is to evaluate the role of PR program to: Improve functional capacity as
assessed by 6MWD test, improve dyspnea level as assessed by MRC dyspnoea scale, improve
PFT and improve ABG.
It was performed on forty-ﬁve COPD patients. They are divided into: 15 patients for aerobic
training group, 15 patients for respiratory training group and 15 patients were control group.
Regarding aerobic training group: There was a statistically signiﬁcant improvement in 6MWD (P-
value 0.001), BODE score (P-value 0.001) and both FEV1 (P-value 0.006) and FVC (P-value 0.002).
Also there was a highly signiﬁcant improvement of FVC% (P-value 0.006) than the respiratory
training group. Regarding respiratory training group: There was a higher % of improvement
(66.7%) of dyspnea score grade within the respiratory training group than aerobic training and con-
trol groups. Although there was no statistically signiﬁcant difference of both physiological parame-
ters and ABG variables between control and respiratory training groups, there was a signiﬁcant
improvement of both FVC (P-value 0.001) and FEV1 (P-value 0.047) and PO2 (P-value 0.001)
and Sat O2 (P-value 0.001) within the respiratory training group.
Short-term PR program (6–8 weeks) especially aerobic training program has the capacity to:
Break the vicious circle of dyspnea, increasing inactivity and exercise intolerance. Improve physio-
logical parameters (FVC and FEV1) and improve some components of BODE index.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).rculosis.
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COPD is ‘‘a preventable and treatable disease state character-
ized by airﬂow limitation that is not fully reversible. The air-
ﬂow limitation is usually progressive and is associated with
an abnormal inﬂammatory response of the lungs to noxious
particles of gases, primarily caused by cigarette smoking [26].
According to an ALA survey, at least half of COPD patients
are expected to beneﬁt from rehabilitation [2].
It is the most common cause of dyspnoea, limitation of
physical activity (due to fatigue, especially to the lower limbs),
decreasing in quality of life and disability [14].
COPD produce signiﬁcant systemic consequence that is
likely to have a profound clinical impact on the management
of COPD:
First, weight loss and skeletal muscle dysfunction clearly
limit the exercise capacity of these patients and, therefore, have
a direct negative effect on their quality of life. Second, weight
loss is a prognostic factor in patients with COPD that, impor-
tantly, is independent of other prognostic indicators, such as
FEV1 or PaO2, that assess the degree of pulmonary dysfunc-
tion [48].
In this regard, Schols et al. [48] showed that prognosis
improved in patients with COPD if body weight could be
regained, despite the absence of changes in lung function.
The creation of the BODE Index (body mass index [B], the
degree of airﬂow obstruction [O] and functional dyspnea [D],
and exercise capacity [E] as assessed by the 6-min walking test),
which has been shown to be better than FEV1 at predicting the
risk of all-cause death and the risk of death from respiratory
causes among patients with COPD [11] (Table 1).
Recent COPD guidelines such as GOLD (Global Initiative
for Chronic Obstructive Pulmonary Disease), NICE (National
Institute for Health and Clinical Excellence) and BTS (British
Thoracic Society) underline the importance of pulmonary
rehabilitation (PR) as a part of an integrative multidisciplinary
approach regardless of the stage of disease [14].
The PR programs that include physical training, education,
nutritional advice and smoking cessation counseling are aimed
to reverse patients to an independent functional status [13].
This is why PR may be considered as one of the mostTable 1 Variables and point values used in the BODE index.
Variable BODE score
0 1 2 3
Body mass index body weight (in kg)/
height (in meters)
>21 621 – –
Airway obstruction: forced expiratory
volume at 1 s (as percentage of
predicted)
>65 50–
65
35–
49
<35
Dyspnea: MMRC 0 or 1 2 3 4
Exercise capacity: 6 min walk test
distance (meters)
P350 250–
349
150–
249
6149
Each 1-point increase in the BODE score correlates to a 30%
increase in the 5-year mortality rate and a 62% increase in mor-
tality from respiratory causes. Individuals with BODE scores of 7–
10 were shown to have a 5-year mortality rate of 80% Celli et al.
[11].important non-pharmacological means to treat COPD,
together with the domiciliary oxygen therapy [14].
The most important effects of PR in COPD patients are:
 Increasing the exertion capacity (exercise tolerance), the
health status and health related quality of life [63,14].
 Reducing dyspnoea, anxiety, depression and disability
[14].
 Decreasing the number of hospital admissions, hospital
visits due to acute exacerbations and use of medical ser-
vices [43].
 Decreasing the costs of health care paid by community
and lengths of hospital admissions for respiratory condi-
tions [29].
These programs can safely run during hospital admission in
outpatient units [29] and in community hospitals as well [60].
PR is grounded on physical exercise programs that aim to
reduce symptoms (especially dyspnoea) and improve lung
functions in terms of exercise tolerance, force and strength [24].
A particular target of these programs is to teach patients on
self-management in COPD, having a big inﬂuence on physical
health, psychological well-being and life expectation. The
patients are encouraged to involve actively in their health care
process, to become more independent in daily life activities and
less dependent on health professionals and very costly medical
resources [41].
A rehabilitation program is considered as being successful if
it meets realistic goals; in order to accomplish this task, the PR
courses must be individually tailored [14].
The aim of the study is to evaluate the efﬁcacy of pul-
monary rehabilitation program as a non-pharmacological
treatment method to:
 Improve functional capacity as assessed by six-minute
walking distance (6MWD) test.
 Improve dyspnea level as assessed by MRC dyspnoea
scale.
 Improve pulmonary function tests.
 Improve arterial blood gas.
Subjects and methods
This study was performed on forty-ﬁve patients presenting to
the chest outpatient clinic of the Kasr El-Aini Hospital. The
selected patients were known COPD on medical therapy.
The study was conducted at chest department; pulmonary
function unit and critical care department in the period from
August 2008 to September 2010.
Selected criteria
(A) Inclusion criteria(1) The patients fulﬁlled the criteria for COPD: the
presence of a post bronchodilator FEV1 < 80%
predicated together with an FEV1/FVC < 0.70
conﬁrm the presence of airﬂow limitation that is
not fully reversible [26].
(2) COPD patients ranging from mild to severe acc-
ording to the Global Initiative for Chronic Obst-
ructive Lung Disease [stages I–IV]. [26].
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Initiative for Chronic Obstructive Lung Disease.
(4) None of the individuals had been engaged in any
exercise-training program before participating in
the study.
(5) All patients are P50 years of age;P10 pack-year
history of cigarette smoking.
(6) Clinically stable COPD (not suffering from a re-
cent respiratory tract infection). This work included two groups:
Group I (non-exercising group): 15 patients on medical
treatment include: short-acting bronchodilators, methyl-xan-
thenes, sometimes inhaled short acting ß2-agonist; inhaled
glucocorticosteroid combined with a short acting ß2-agonist
or inhaled short acting anticholinergic combined with short
acting ß2-agonist.
Group II (exercising group): 30 patients on medical treat-
ment in addition to pulmonary rehabilitation program:
IIa-15 patients subjected to respiratory muscle training
using incentive spirometry and respiratory exercises.
IIb-15 patients subjected to hospital based supervised aero-
bic training program.Study design
All patients were subjected to:
(1) Full history taking including smoking history and medi-
cal history.
(2) Clinical examination including general and local chest
examination.
(3) Routine laboratory parameters include: complete blood
count (CBC), liver and kidney functions. Plain chest X-
ray.
(4) Pre and post study arterial blood gas analysis to estimate
PaCO2, PaO2, and SO2.
(5) Pre and post study pulmonary function test: Flow/
volume loop was performed using body plethys-
mography with highly transparent box; Sensor-medics
V max series, 2130 Spiro meter, V6200 Auto box,
6200DL.
(6) Pre and post study body weight and body mass index
assessment.
Results
Results were tabulated and statistically analyzed after 6–8 weeks
of training program
As regards training groups (Both aerobic and respiratory
training groups):
 There was an improvement in the baseline dyspnea score
grade (MRC grade 2/3) when compared with the control
group. However did not reach a statistically signiﬁcant
difference.
 There was no statistically signiﬁcant improvement in BMI.As regards aerobic training group:
 There was a statistically signiﬁcant improvement in 6MWD
with an increase of 78 m.
 There was a statistically signiﬁcant improvement in the
BODE score.
 There was a statistically signiﬁcant improvement of both
FEV1 and FVC physiological parameters when compared
with the control group.
 There was a highly signiﬁcant improvement of FVC%
parameter than the respiratory training group.
 Although there was no statistically signiﬁcant difference in
ABG variables between the control group and the aerobic
training group, there was a statistically signiﬁcant improve-
ment of both PO2 and O2 Sat within aerobic training group.
As regards respiratory training group:
 There was a higher % of improvement (66.7%) of dyspnea
score grade within respiratory the training group than the
aerobic training group and the control group.
 Although there was no statistically signiﬁcant difference of
physiological parameters between the control group and the
respiratory training group, there was a statistically signiﬁ-
cant improvement of both FVC and FEV1 parameters
within the respiratory training group.
 Although there was no statistically signiﬁcant difference in
ABG variables between the control group and the respira-
tory training group, there was a statistically signiﬁcant
improvement of both PO2 and Sat O2 within the respiratory
training group.
Of 45 participants, 19 (42.2%) subjects walk slower than
people of same age do on the level because of breathlessness
(2 score), 26 (57.8%) subjects stop for breath after walking
about 100 m or after a few minutes on the level (3 score)
(Table 2).
This Table 3 shows that there was a statistically signiﬁcant
difference in the baseline MRC dyspnea score (P-value 0.000)
between control group, respiratory training group and aerobic
training group.
Table 4 shows that there was no statistically signiﬁcant dif-
ference (P-value >0.66) of BMI between the control group,
the respiratory training group and aerobic training group after
training program.
Table 5 shows that there was no statistically signiﬁcant dif-
ference (P-value 0.472) of MRC dyspnea score between con-
trol group, respiratory training group and aerobic training
group after training program. Of 45 participants, 23 (51.1%)
subjects improved their dyspnea level (score 1) with higher per-
centage of improvement (66.7%) within respiratory training
group than aerobic training group and control group.
Table 6 shows that there was a statistically signiﬁcant dif-
ference in the Mean ± S.D of FVC% (P-value 0.002) between
the control group (60.87 ± 20.31), respiratory training group
(68.67 ± 18.41) and aerobic training group (85.87 ± 17.01)
after training program.
It also showed the presence of statistically signiﬁcant differ-
ence in the Mean ± S.D of FEV1% (P-value 0.014) between
the control group (34.67 ± 13.70), respiratory training group
(43.47 ± 17.20) and aerobic training group (51.00 ± 18.97)
after training program.
Table 7 shows that there was no statistically signiﬁcant
improvement (P-value >0.05) in arterial blood gas variables
Table 7 ABG analysis for study groups after 6–8 weeks of PR program.
Blood gas analysis Control group
(n= 15)
Respiratory training
group (n= 15)
Aerobic training
group (n= 15)
Total study
participants (n= 45)
P-value
Paco2 mmHg mean ± S.D 44.53 ± 5.13 45.40 ± 9.17 42.77 ± 5.63 44.16 ± 6.80 0.465
Pao2 mmHg mean ± S.D 75.73 ± 14.54 75.20 ± (14.17) 80.70 ± (13.84) 78.94 ± 14.29 0.102
Sat O2 mean ± S.D 94.01 ± 3.46 94.20 ± (2.96) 94.90 ± (2.71) 94.72 ± 3.05 0.398
Table 2 Characteristics of the study groups.
Characteristic Control group
(n= 15)
Respiratory
training
group (n= 15)
Aerobic training
group (n= 15)
Total study
participants
(n= 45)
P-value
Age (P50 years) mean ± S.D 60.53 ± 8.07 59.80 ± 7.93 58.87 ± 8.76 59.73 ± 8.10 0.211
BMI (kg/m2) mean ± S.D. 25.75 ± 5.09 26.88 ± 4.88 25.54 ± 3.93 26.06 ± 4.59 0.68
Smoking index (No.cig/day/No. of years)
mean ± S.D.
763.33 ± 696.02 520.00 ± 607.33 353.33 ± 425.72 545.56 ± 598.46 0.779
Current smokers n (% within Group) 9 (60%) 7 (46.66%) 7 (46.66%) 23 (51.11%)
Table 3 Baseline medical research council dyspnea score of the study groups.
Dyspnea score Control group (n= 15) Respiratory training
group (n= 15)
Aerobic training
group (n= 15)
Total study
participants (n= 45)
P-value
2 n (% within Group) 9 (60.0%) 10 (66.7%) 0 (0.0%) 19 (42.2%) 0.000*
3 n (% within Group) 6 (40.0%) 5 (33.3%) 15 (100%) 26 (57.8%)
* P-value <0.05 statistically signiﬁcant.
Table 4 Body mass index for study groups after 6–8 weeks of pulmonary rehabilitation program.
Characteristic Control group Respiratory training group Aerobic training group Total study participants P-value
(n= 15) (n= 15) (n= 15) (n= 45)
BMI (kg/m2) Mean ± S.D 25.72 ± 5.11 26.91 ± 4.917 25.54 ± 3.93 26.06 ± 4.61 0.660
Table 5 MRC dyspnea scores for study groups after 6–8 weeks of PR Program.
Dyspnea score Control group
(n= 15)
Respiratory training
group (n= 15)
Aerobic training
group (n= 15)
Total study
participants (n= 45)
P-value
1 n (% within Group) 5 (33.3%) 10 (66.7%) 8 (53.3%) 23 (51.1%) 0.472
2 n (% within Group) 7 (46.7%) 3 (20.0%) 5 (33.3%) 15 (33.3%)
3 n (% within Group) 3 (20.0%) 2 (13.3%) 2 (13.3%) 7 (15.6%)
Table 6 Spiro metric data for study groups after 6–8 weeks of pulmonary rehabilitation program.
Spiro metric date Control group
(n= 15)
Respiratory training
group (n= 15)
Aerobic training group (n= 15) Total study
participants (n= 45)
P-value
FVC% mean ± S.D 60.87 ± 20.31 68.67 ± 18.41 85.87 ± 17.01 71.80 ± 21.04 0.002*
FEV1% mean ± S.D 34.67 ± 13.70 43.47 ± 17.20 51.00 ± 18.97 43.04 ± 17.72 0.014*
FEV1/FVC% mean ± S.D 44.77 ± 11.18 51.27 ± 14.47 46.27 ± 12.29 47.43 ± 12.74 0.361
FEF25–75% mean ± S.D 12.20 ± 6.95 20.40 ± 13.67 24.33 ± 19.56 18.98 ± 14.92 0.065
* P-value < 0.05 statistically signiﬁcant.
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Table 8 Comparison of BMI before and after aerobic training
program.
Characteristic Aerobic training
group (n= 15)
P-value
Before After
BMI (kg/m2) mean ± S.D 25.54 ± 3.93 25.54 ± 3.93 1.000
Table 9 Comparison of MRC dyspnea score before and after
aerobic training program.
Dyspnea score Aerobic training group (n= 15) P-value
Before After
1 n (% within Group) 0 (0.0%) 8 (53.3%) 0.02*
2 n (% within Group) 0 (0.0%) 5(33.3%)
3 n (% within Group) 15 (100%) 2 (13.3%)
* P-value <0.05 statistically signiﬁcant.
Table 10 Comparison of spiro metric variables before and
after aerobic training program.
Spirometric variables Aerobic training group
(n= 15)
P-
value
Before After
FVC% mean ± S.D 73.40 ± 20.70 85.87 ± 17.01 0.001*
FEV1% mean ± S.D 48.40 ± 20.95 51.00 ± 18.97 0.127
FEV1/FVC%
mean ± S.D
49.20 ± 12.69 46.27 ± 12.29 0.033
FEF25–75% mean ± S.D 24.40 ± 19.62 24.33 ± 19.56 0.972
* P-value <0.05 statistically signiﬁcant.
Table 11 Comparison of ABG variables before and after
aerobic training program.
Blood gas variables Aerobic training
group (n= 15)
P-
value
Before After
Paco2 mmHg
mean ± S.D
41.79 ± 6.62 42.77 ± 5.63 0.333
Pao2 mmHg mean ± S.D 75.00 ± 13.78 80.70 ± 13.84 0.001
*
Sat O2 mean ± S.D 93.20 ± 3.18 94.90 ± 2.71 0.002
*
* P-value <0.05 statistically signiﬁcant.
Table 12 Comparison of 6 min walk test before and after
aerobic training program.
6 min walk test in meters Aerobic training
group (n= 15)
P-value
Before After
6 min walk test
mean ± S.D
41.53 ± 9.55 119.53 ± 27.39 0.001*
* P-value <0.05 statistically signiﬁcant.
Table 13 Comparison of BODE index before and after
aerobic training program.
BODE index Aerobic training
group (n= 15)
P-value
Before After
BODE index mean ± S.D 6.80 ± 1.32 5.00 ± 1.73 0.001*
* P-value <0.05 statistically signiﬁcant.
Table 14 Change in BODE index after aerobic training
program.
BODE index after aerobic
training program
Aerobic training group (n= 15)
Not improved Improved*
n (% within the Group) 2 (13.33%) 13 (86.6%)
* Improvement: at least one unit change in the BODE index.
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training group after training program.
Table 8 shows that there was no statistically signiﬁcant dif-
ference in the Mean ± S.D of BMI (P-value 1.00) before
(25.54 ± 3.93) and after (25.54 ± 3.93) treadmill exercise
within the aerobic training group.
Table 9 shows that there was statistically signiﬁcant
improvement of MRC dyspnea score (P-value 0.02) after
treadmill exercise within the aerobic training group.
This Table 10 shows that there was a statistically signiﬁcant
increase in the Mean ± S.D of FVC% (P-value 0.001) after
treadmill exercise within the aerobic training group. It also
showed that there was statistically signiﬁcant decrease in the
Mean ± S.D of FEV1/FVC% (P-value 0.033) after treadmill
exercise within the aerobic training group.
Table 11 shows that there was statistically signiﬁcant
increase in the Mean ± S.D of PaO2 (P-value 0.001) after
treadmill exercise within the aerobic training group. It also
shows that there was statistically signiﬁcant increase in the
Mean ± S.D of Sat O2 (P-value 0.002) after treadmill exercise
within the aerobic training group.
Table 12 shows that the change in 6-min walking distance
was statistically signiﬁcant (P-value 0.001). It showed that
there was a signiﬁcant increase in Mean ± S.D of 6 min walk
distance after treadmill exercise within aerobic training group.Table 13 shows that there was statistically signiﬁcant
improvement of the BODE score (P-value 0.001) after tread-
mill exercise within the aerobic training group (Table 14).
Table 15 shows that there was no statistically signiﬁcant
difference in the Mean ± S.D of BMI (P-value 0.31) before
(26.88 ± 4.88) and after (26.91 ± 4.917) incentive spirometry
and respiratory exercises within the respiratory training group.
Table 16 shows that there was statistically signiﬁcant
improvement of MRC dyspnea score (P-value 0.019) after
incentive spirometry and respiratory exercises within the
respiratory training group.
Table 17 shows that there was statistically signiﬁcant
increase in the Mean ± S.D of FVC percentage (P-value
0.001) after incentive spirometry and respiratory exercises
within respiratory training group. It also showed that there
was statistically signiﬁcant increase in the Mean ± S.D of
Table 15 Comparison of BMI before and after respiratory
training program.
Characteristic Respiratory training
group (n= 15)
P-value
Before After
BMI (kg/m2) mean ± S.D 26.88 ± 4.88 26.91 ± 4.917 0.317
Table 16 Comparison of MRC dyspnea score before and
after respiratory training program.
Dyspnea score Respiratory training group
(n= 15)
P-value
Before After
1 n (% within Group) 0 (0.0%) 10 (66.7%) 0.019*
2 n (% within Group) 10 (66.7%) 3 (20.0%)
3 n (% within Group) 5 (33.3%) 2 (13.3%)
* P-value <0.05 statistically signiﬁcant.
Table 17 Comparison of spirometric data before and after
respiratory training program.
Spirometric data Respiratory training group
(n= 15)
P-
value
Before After
FVC% mean ± S.D 57.87 ± 12.42 68.67 ± 18.41 0.001*
FEV1% mean ± S.D 40.00 ± 16.22 43.47 ± 17.20 0.047*
FEV1/FVC%
mean ± S.D
51.60 ± 13.50 51.27 ± 14.47 0.780
FEF25–75% mean ± S.D 19.20 ± 11.47 20.40 ± 13.67 0.721
* P-value <0.05 statistically signiﬁcant.
Table 18 Comparison of ABG variables before and after
respiratory training program.
Blood gas variables Respiratory training
group (n= 15)
P-
value
Before After
PCO2 mmHg
mean ± S.D
46.26 ± 9.83 45.40 ± 9.17 0.231
PO2 mmHg mean ± S.D 70.50 ± 15.29 75.20 ± 14.17 0.001
*
Sat O2 mean ± S.D 92.50 ± 3.72 94.20 ± 2.96 0.001
*
* P-value <0.05 statistically signiﬁcant.
Table 19 Comparison of sustained maximum volume reached
in incentive spirometry before and after respiratory training
program.
Volume
reached cc/s
Respiratory training
group (n= 15)
P-value
Before After
Volume reached
mean ± S.D
600.00 ± 0.000 1,080.00 ± 152.13 0.000*
* P-value <0.05 statistically signiﬁcant.
Table 20 Comparison of FVC% and FEV1% Variables
between the Control Group and the Aerobic Training Group
after the Training program.
Spirometric date Control group
(n= 15)
Aerobic training
group (n= 15)
P-value
After training program
FVC% mean ± S.D 60.87 ± 20.31 85.87 ± 17.01 0.002*
FEV1% mean ± S.D 34.67 ± 13.70 51.00 ± 18.97 0.006*
* P-value <0.05 statistically signiﬁcant.
Table 21 Comparison of FVC% and FEV1% variables
between the control group and the respiratory training group
after the training program.
Spirometric date Control group
(n= 15)
Respiratory
training
group (n= 15)
P-value
After training program
FVC% mean ± S.D 60.87 ± 20.31 68.67 ± 18.41 0.220
FEV1% mean ± S.D 34.67 ± 13.70 43.47 ± 17.20 0.074
Table 22 Comparison of FVC% and FEV1% variables
between the aerobic training group and the respiratory training
group after the training program.
Spiro metric date Aerobic
training
group
(n= 15)
Respiratory
training
group
(n= 15)
P-value
After training program
FVC% mean ± S.D 85.87 ± 17.01 68.67 ± 18.41 0.006*
FEV1% mean ± S.D 51.00 ± 18.97 43.47 ± 17.20 0.164
* P-value <0.05 statistically signiﬁcant.
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and respiratory exercises within the respiratory training group.
Table 18 shows that there was a statistically signiﬁcant
increase in the Mean ± S.D of PaO2 (P-value 0.001) after
incentive spirometry and respiratory exercises within the
respiratory training group. It also showed that there was sta-
tistically signiﬁcant increase in the Mean ± S.D of Sat O2
(P-value 0.001) after incentive spirometry and respiratory exer-
cises within respiratory training group.Table 19 shows that there was a statistically signiﬁcant
improvement of volume reached (P-value 0.000) after incentive
spirometry and respiratory exercises within the respiratory
training group.
Table 20 shows that there was statistically signiﬁcant
increase of Mean ± S.D of both spirometric parameter FVC
percentage and FEV1 of the aerobic training group than the
control group after training program (P-value <0.05).
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difference in the Mean ± S.D of spirometric data variables
(FVC% and FEV1%) (P-value >0.05) between the respira-
tory training group and the control group after training
program.
Table 22 shows that there was statistically signiﬁcant
increase of Mean ± S.D of FVC percentage (P-value 0.006)
of the aerobic training group than the respiratory training
group after training program.
While it showed no statistically signiﬁcant improvement (P-
value 0.16) in the Mean ± S.D of FEV1% between the aerobic
training group (51.00 ± 18.97) and the respiratory training
group (43.47 ± 17.20) after training program.
Discussion
To clarify the effect of pulmonary rehabilitation program on
COPD patients, the present study conducted a training pro-
gram of 6–8 weeks. Most previous studies were fully consistent
with this they showed that the duration of pulmonary rehabil-
itation program has been more than 6 weeks based on the
training effect in normal subjects [50,65].
In another study, Green et al. [28] compared 4 weeks with
7 weeks of rehabilitation and concluded that 4 weeks of
rehabilitation was less effective.
While Sneed and Paul [54] found that longer rehabilitation
programs (6 months or longer) yield signiﬁcantly greater
effects, concluded that although measurable physiological
changes may occur within weeks, behavioral changes may
require longer time periods.
Regarding the intensity of aerobic exercise
The present study implemented high intensity training pro-
gram that targeted 80–85% of the individually determined
maximal heart rate in-order to maximize the training effects.
Initially the intensity should be at 60–70% for the ﬁrst 3–4 ses-
sions. As patients’ tolerance for exercise improved, the dura-
tion of walking increase gradually and the target is increased
by 5–10% of the maximum heart rate. After 4 weeks of train-
ing, exercise intensity achieves a level of 80% of maximum
heart rate.
Similarly Puente-Maestu et al. [44] and Gimenez et al. [25]
conﬁrmed that high training intensity is required to elicit phys-
iologic training effects.
In another study Vallet et al. [59] compared an individu-
ally tailored exercise regimen that targeted the heart rate at
anaerobic threshold to a standard lower intensity regimen
that targeted 50% of the maximal heart rate. The individu-
ally tailored regimen increased O2 pulse and reduced lactate
accumulation compared with the standard regimen. They
proved that Individualized-training decreases lactate accu-
mulation at higher intensity exercise levels. While Clark
et al. [15] examined the efﬁcacy of low-intensity isotonic
exercises of the upper and lower extremities performed at
home in a group of 40 patients with COPD. They demon-
strated a dramatic improvement in treadmill walking time
and suggested that their program would be applicable in
patients with COPD with a wide range of functional
defects.Regarding the characteristics of the study participants
The present study showed that the mean age of study groups
was 59.73 years (range, 50–80 years old). These patients are
appropriate candidates for the study and not to be excluded
on the basis of age alone as shown in Table 2.
Some pulmonary rehabilitation studies have excluded
patients older than 70 years (The McGavin et al., 1977 and
[57] rationale for age exclusion was not given in these studies;
however, all three also excluded patients with other disabling
conditions, including arthritis, ischemic heart disease, and
heart failure. Thus Older elderly patients may have been con-
sidered inappropriate for pulmonary rehabilitation because it
was believed that they were ‘‘too old,’’ that they would not tol-
erate aggressive treatment [62], or that the physiologic effects
of aging and comorbid illness would limit their ability to
improve exercise capacity. Other studies [17] suggested that
these beneﬁts can be extended to very elderly patients with
mean age approaching 80 years.
Regarding outcome measures post-rehabilitation program
One of the features of the present study was stratiﬁcation of the
patients for severity of disability using the MRC Dyspnoea
grade
Using this approach, the present study showed that there was
an improvement in baseline dyspnea score grade (MRC grade
2/3) of training groups following individualized pulmonary
rehabilitation program when compared with the control
group. However did not reach a statistically signiﬁcant differ-
ence (Table 5).
Wedzicha et al. [61] were fully consistent with this; they
showed that the effect of exercise training in COPD patients
might depend on the initial level of dyspnoea. Patients with
moderate dyspnoea (MRC grade 2/3), who were regularly
mobile outside the home, showed quite large improvements
in exercise capacity after physical training. In contrast, patients
with severe disability (MRC grade 4), who were largely house-
bound owing to dyspnoea, showed no improvement in exercise
performance following individualized physical training.
The present study also reported a higher % of improvement
(66.7%) within the respiratory training group than the aerobic
training group and the control group (Table 5).
Harver et al. [31] were fully consistent with this, they found
that targeted inspiratory muscle training (IMT) results in sig-
niﬁcant increases in respiratory muscle function and signiﬁcant
reductions in dyspnea, this supports the concept that an
increase in the strength of inspiratory muscles can ameliorate
dyspnea.
Other study of Lisboa et al. [36] found that the trained
patients were able to make greater efforts and perform harder
tasks than they were before IMT and were able to carry out
activities faster without dyspnea.
Also two exhaustive meta-analyses Smith et al. [55] and
Lotters et al. [37] have focused on the effectiveness of IMT
in patients with COPD: results have shown a compelling body
of evidence in favor of such training, so far included by the
joint statement from the American College of Chest
Physicians and American Association of Cardiovascular and
Pulmonary Rehabilitation Committee (ACCP/AACVPR)
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itation programs [1]. In particular, it has been demonstrated
that placing a load on the respiratory muscle during contrac-
tion is sufﬁcient in increasing strength, thus causing a mean-
ingful reduction of breathlessness and an increase of physical
exercise ability [37]. Additionally, the trial that evaluated the
1-year effects of IMT provides evidence that IMT also
decreases the use of healthcare services, which may translate
into economic beneﬁts as well [4].
There is still debate as regards to which is the mechanism
responsible for the enhanced inspiratory muscle force output
(strength) following IMT. Some authors argue that inspiratory
muscles of COPD patients are already well adapted to chronic
loading and do not express any adaptation in response to
training. Nonetheless, a substantial increase in the proportion
of type I ﬁbers (by 38%) and in the size of type II ﬁbers (by
21%) of the external intercostal muscles have been found after
IMT [45]. These structural changes presumably represent
adaptive effects with the genuine remodeling of inspiratory
muscle structure during IMT.
While Guyatt et al. [30] used a COPD-speciﬁc measure of
quality of life Chronic Respiratory Disease Questionnaire
(the CRQ) in the clinical assessment of an IMT protocol were
not fully consistent with this. They found no change in quality
of life after inspiratory muscle training (IMT) at home. This
ﬁnding might have been expected because Dekhuijzen et al.
[19] had already shown that IMT alone did not inﬂuence psy-
chological parameters, although they did not use the CRQ. On
the other hand, they showed that a combination of IMT and
conventional rehabilitation decreased anxiety and depression.
Exercise tolerance was measured using the 6-min walking
distance (6MWD)
Timed walking tests such as the six-minute walking test
(6MWT) have gained popularity for use in clinical practice
and research setting [32] to assess changes in functional capac-
ity following pulmonary rehabilitation intervention [33].
The present study showed that 6MWD increased by 78 m
after 6–8 weeks of aerobic training program. This improve-
ment was statistically signiﬁcant (Table 12). Redelmeier et al.
[46] suggested that the minimal clinically meaningful increase
in the 6MWD is about 54 m.
The improvement in exercise capacity after aerobic train-
ing program may be due to: (1) reconditioning, this reinforces
the participation of chronic reduction in conditioning as the
main mechanism of the peripheral skeletal muscle dysfunc-
tion and exercise intolerance in COPD patients [38]. (2)
Improving ventilatory muscle function. (3) desensitization to
dyspnea.
This ﬁnding correlated with a meta-analysis done by
Bendtrup and co-workers [5], in a controlled 12-week study
of outpatient pulmonary rehabilitation, the 6-min walk dis-
tance increased by 80 m at 6 week (half-way in the program),
113 m at the end of the program, and 96 m 12 weeks after
the program ended. Other study demonstrated that 6 MWD
increased by 71.75 m after 6 weeks of outpatient PR [64].
While De-Torres et al. [20] demonstrated that the mean
improvement in 6 MWD was 65 m after 6–8 weeks of PR.
Other study Shetty and co-worker [51] noted an increase of
78.41 m in 6 MWD after six months of outpatient and
home-based program.The BODE index, which integrates body mass index, airﬂow
limitation (forced expiratory volume in ﬁrst second), dyspnoea
and 6-min walk distance
The present study used the BODE index to evaluate the effect
of treadmill exercise within aerobic training group. It demon-
strated that 13 patients or 86.6% showed a statistically signiﬁ-
cant improvement in BODE score after 6–8 weeks of aerobic
training program (Tables 4 and 5). This ﬁnding supports the
use of this multi-dimensional index to evaluate the effects of
pulmonary rehabilitation, as has been in study done by Cote
and Celli [16].
Although PR has minimal effect on lung function, it
improves dyspnea Lacasse et al. [35], exercise capacity
Troosters et al. [58], health status Bowen et al. [8] and health-
care resource utilization Bourbeau et al. [7]. Two of these out-
comes, dyspnoea and exercise capacity, are components of the
BODE index. As such, the BODE index could be used to
evaluate the effect of PR. For this Cote and Celli [16] deﬁned
one unit change in BODE as being clinically signiﬁcant
because it implies a change in any of its component of a mag-
nitude large enough to inﬂuence clinical outcomes.
Indeed, one unit change in the Modiﬁed Medical Research
Council scale predicts mortality Nishimura et al. [42].
Likewise, one unit change in the 6MWD in the BODE score
far exceeds the 50 m considered to be clinically signiﬁcant
changes for this test Redelmeier et al. [46]. Similarly, one unit
change in the FEV1 component of the BODE index reﬂects the
thresholds that have been accepted by the ATS/European
Respiratory Society and Global Initiative for Chronic
Obstructive Lung Disease (GOLD) as the basis for the physio-
logical staging of COPD [12].
Using this conservative threshold, Cote and Celli [16] found
that 71% of the patients participating in PR improved the
BODE index, a ﬁnding that supports that BODE is a valid tool
to evaluate the integrated response to interventions.
Different physiological parameters and BMI are used as
surrogates for clinical status assessment
The present study demonstrated that short term pulmonary
rehabilitation (6–8 weeks) didn’t show a statistically signiﬁcant
improvement in BMI after training program (Table 4, 8 and
15). While Stav et al. [56] found that prolonged pulmonary
rehabilitation program (three years) may improve BMI.
No signiﬁcant changes in BMI were shown in this prospec-
tive study due to: (1) Measurement of BMI may not accurately
reﬂect changes in body composition in these patients and that
measurement of FFM may be required to estimate body cell
mass [49]. (2) More-over Fuld et al. [23] reported that increases
in total FFM only when the rehabilitation process included
nutritional support or supplementation with speciﬁc agents,
such as testosterone or creatine.
The present study showed a statistically signiﬁcant
improvement in both FVC% and FEV1% after 6–8 weeks of
pulmonary rehabilitation (Table 6).
In contrast other studies, [10] no signiﬁcant modiﬁcation of
pulmonary function was marked after a training program.
Pulmonary rehabilitation causes modiﬁcation in peripheral
myopathy but not ventilatory limitation. The airﬂow lim-
itation in most cases is both progressive and associated with
an abnormal inﬂammatory response of the lungs to noxious
particles or gases [39].
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signiﬁcant improvement of both FEV1 and FVC physiological
parameters of aerobic training group when compared with
control group (Table 20), Additionally there was a highly sig-
niﬁcant improvement of FVC parameter of aerobic training
group than respiratory training group after training program
(Table 22).
This ﬁnding supports the concept that COPD is associated
with local and systemic manifestations [21] and that aerobic
training program may produce great improvements in skeletal
muscle function (both respiratory and peripheral muscles).
Gohar [27] was fully consistent with this, he found that
there was a signiﬁcant improvement of both FVC and FEV1
parameters in COPD patients undergo lower limb exercise
for 6 weeks. In contrast, Ries et al. [47] found that lower limb
training may not improve spirometric values.
Other studies have shown some improvement in FVC which
may have been due to improved respiratorymuscle function and
a reduction in small airways disease, the improvement in FEV1
in those cases was small and not statistically signiﬁcant [9].
While Stav et al. [56] demonstrated that outpatient pro-
longed pulmonary rehabilitation program (three years) did
not improve FEV1, but has an important beneﬁcial impact
on the rate of FEV1 decline, In addition, it increased endur-
ance time and work. As the result PR should be considered
as a disease modiﬁer Sircar et al. [53], in addition to previously
reported advantages of this treatment modality, for COPD
patients.
Although the present study showed that there was no sta-
tistically signiﬁcant difference of physiologic parameters
between control and respiratory group (Table 21), there was
a statistically signiﬁcant improvement of both FEV1 and
FVC parameters within the respiratory training group after
training program (Table 17). This improvement may be related
to the concept that breathing exercise may improve ventilation
and increase strength, endurance and coordination of respira-
tory muscles [34].
Esteve and et al. [22] found that breathing pattern training,
enhanced with visual feedback increased the FEV1 and FVC in
patients with COPD. While other studies Singh et al. [52]
reported no improvement following pulmonary rehabilitation
having breathing exercises as a component.
Arterial blood gas variables
Although the present study showed that there was no sta-
tistically signiﬁcant difference in arterial blood gas variables
between the control group, the respiratory training group
and the aerobic training group after training program
(Table 7), there was a statistically signiﬁcant improvement of
both blood gas variables PaO2 and SO2 within the aerobic
training group and the respiratory training group after training
program (Tables 11 and 18).
Impaired respiratory mechanics (dynamic hyperinﬂation)
seems to play a major role limiting exercise tolerance in these
patients. During exercise in COPD, a balance is struck between
the need for ventilation and the high cost of breathing. The
most common end-result is a small raise in arterial PCO2
and similar fall in PaO2. However, unless pulmonary carbon
monoxide transfer capacity (DLCO) is severely impaired
(<50% predicted value), PaO2 does not fall during exercise,
and may even increase in some subjects [18].Dantzker and D’Alonzo [18] showed that VA/Q mismatch
is usually unaltered from that at rest, that shunts do not
develop, and that diffusion limitation does not occur. This is
even the case when COPD is severe. Other studies Barbera
et al. [3] showed that in milder disease, there is evidence that
small improvements in VA/Q relationships may occur on exer-
cise, providing a partial reason for improvement in arterial
PO2.
Minh et al. [40] demonstrated that in many patients with
chronic obstructive pulmonary disease (COPD), considerable
hypoxemia develops during exercise, while Bianchi et al. [6]
reported that breathing exercises improved gas exchanges.
Conclusion
The present study found that short-term pulmonary rehabil-
itation program especially aerobic training program has the
capacity to:
 Break the vicious circle of dyspnea, increasing inactivity
and exercise intolerance – the hallmark features of COPD
patients.
 Improve physiological parameters (FVC and FEV1).
 Improve some components of BODE index.
These ﬁndings suggested that even if the program duration
does not exceed 8 weeks, it can still beneﬁt patients with
COPD.
Recommendations
This prospective study provides a strong, growing evidence
base supporting the beneﬁts of short-term pulmonary rehabil-
itation for patients.
Conﬂict of interest
Role of aerobic and anaerobic training of respiratory muscles
as a part of pulmonary rehabilitation in the COPD as a non
pharmacologic treatment.
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